It was observed that the presence of CD8+ cells in the tumour compartment in resected non-small-cell lung cancer, detected either by IHC or by RTqPCR, is highly associated with improved progression-free survival (PFS) and overall survival (OS) [56]. This evidence concerns the gene CD8A and neoplasm.